Indo US Bio-Tech Ltd Q4 FY2025-2026 Results: Summary
Revenue | ₹26.05Cr |
Net Profits | ₹1.97Cr |
Net Profit Margins | 7.56% |
Indo US Bio-Tech Ltd’s revenue fell -22.24% since last year same period to ₹26.05Cr in the Q4 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 14.25% jump in its revenue since last 3-months.
Indo US Bio-Tech Ltd’s net profit fell -46.47% since last year same period to ₹1.97Cr in the Q4 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -34.33% fall in its net profits since last 3-months.
Indo US Bio-Tech Ltd’s net profit margin fell -31.16% since last year same period to 7.56% in the Q4 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -42.53% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Indo US Bio-Tech Ltd in Q4 results 2025?
The revenue for Indo US Bio-Tech Ltd in the Q4 results 2025 was ₹26.05Cr.
What was the net profit for Indo US Bio-Tech Ltd in Q4 results 2025?
The net profit for Indo US Bio-Tech Ltd in the Q4 results 2025 was ₹1.97Cr.
What was the net profit margin for Indo US Bio-Tech Ltd in Q4 results 2025?
The net profit margin for Indo US Bio-Tech Ltd in the Q4 results 2025 was 7.56%.
What was the revenue for Indo US Bio-Tech Ltd in Q4 results 2024?
The revenue for Indo US Bio-Tech Ltd in the Q4 results 2024 was ₹33.50Cr.
What was the net profit for Indo US Bio-Tech Ltd in Q4 results 2024?
The net profit for Indo US Bio-Tech Ltd in the Q4 results 2024 was ₹3.68Cr.
What was the net profit margin for Indo US Bio-Tech Ltd in Q4 results 2024?
The net profit margin for Indo US Bio-Tech Ltd in the Q4 results 2024 was 10.99%.
